Vinay Prasad, the FDA's Biologics head, was reinstated after facing pressure from right-wing activists and criticism over his handling of a gene therapy drug.
Israel plans to occupy Gaza City, disarm Hamas, and transfer control to Arab forces, raising concerns over humanitarian risks and hostage safety.
Vinay Prasad, the FDA's Biologics head, was reinstated after facing pressure from right-wing activists and criticism over his handling of a gene therapy drug.
Israel plans to occupy Gaza City, disarm Hamas, and transfer control to Arab forces, raising concerns over humanitarian risks and hostage safety.